Analyzing Zealand Pharma A/S (OTCMKTS:ZLDPF) & FirstGroup (OTCMKTS:FGROY)

FirstGroup (OTCMKTS:FGROY) and Zealand Pharma A/S (OTCMKTS:ZLDPF) are both transportation companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, earnings, analyst recommendations, valuation and risk.

Volatility and Risk

FirstGroup has a beta of 1.17, indicating that its stock price is 17% more volatile than the S&P 500. Comparatively, Zealand Pharma A/S has a beta of 0.88, indicating that its stock price is 12% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent recommendations for FirstGroup and Zealand Pharma A/S, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
FirstGroup	0	0	0	0	0.00
Zealand Pharma A/S	0	0	2	1	3.33

Profitability

This table compares FirstGroup and Zealand Pharma A/S’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
FirstGroup	N/A	N/A	N/A
Zealand Pharma A/S	-1,375.16%	-18.49%	-16.57%

Valuation & Earnings

This table compares FirstGroup and Zealand Pharma A/S”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
FirstGroup	$5.93 billion	0.24	-$19.99 million	N/A	N/A
Zealand Pharma A/S	$49.75 million	154.60	-$102.18 million	($2.43)	-44.57

FirstGroup has higher revenue and earnings than Zealand Pharma A/S.

Summary

FirstGroup beats Zealand Pharma A/S on 6 of the 10 factors compared between the two stocks.

About FirstGroup

FirstGroup plc provides public transport services in the United Kingdom. The company operates through First Bus and First Rail segments. The First Bus segment offers local bus services with a fleet of approximately 4,800 buses in the United Kingdom. The First Rail segment operates a passenger rail network that provides long-distance, commuter, regional, and sleeper services through a portfolio of Great Western Railway, South Western Railway, and Avanti West Coast franchises; and hull trains and Lumos. FirstGroup plc was founded in 1986 and is based in London, the United Kingdom.

About Zealand Pharma A/S

Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. The company offers Dasiglucagon, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon that is in Phase III clinical trials for treating congenital hyperinsulinism. The company is also developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. The company was incorporated in 1997 and is based in Søborg, Denmark.